Market Currents
BG Medicine (BGMD +78%) nearly doubles in value today after the company says it's CardioSCORE...
-
Tuesday, December 11, 2012, 10:31 AM ETBG Medicine (BGMD +78%) nearly doubles in value today after the company says it's CardioSCORE test has been awarded a CE Mark enabling it for commercial sale in the EU and other countries that recognize the CE Mark. The CardioSCORE is a patented diagnostic blood test designed to improve risk prediction of major cardiovascular events. The test isn't yet available in the U.S., however the company is currently in discussions with the FDA to obtain 510(k) clearance.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
